Different anti-Candida activities of two human lactoferrin-derived peptides, Lfpep and kaliocin-1.
about
Antifungal activity of synthetic peptide derived from halocidin, antimicrobial peptide from the tunicate, Halocynthia aurantium.Peptide-based Antifungal Therapies against Emerging Infections.Candidacidal activity of synthetic peptides based on the antimicrobial domain of the neutrophil-derived protein, CAP37The role of micro-organisms (Staphylococcus aureus and Candida albicans) in the pathogenesis of breast pain and infection in lactating women: study protocolThe oligo-acyl lysyl antimicrobial peptide C₁₂K-2β₁₂ exhibits a dual mechanism of action and demonstrates strong in vivo efficacy against Helicobacter pylori.Efficacy of the antimicrobial peptide TP4 against Helicobacter pylori infection: in vitro membrane perturbation via micellization and in vivo suppression of host immune responses in a mouse modelPeptide antimicrobial agents.Antifungal immunotherapy and immunomodulation: a double-hitter approach to deal with invasive fungal infections.Inhibitory Effects of Synthetic Peptides Containing Bovine Lactoferrin C-lobe Sequence on Bacterial GrowthThe Antifungal Activity of Lactoferrin and Its Derived Peptides: Mechanisms of Action and Synergy with Drugs against Fungal Pathogens.Antimicrobial peptides: key components of the innate immune system.Caring for new mothers: diagnosis, management and treatment of nipple dermatitis in breastfeeding mothers.Dermatoses of the breast in lactation.Immunotherapy of Fungal Infections.Antifungal Mechanism of Action of Lactoferrin: Identification of H+-ATPase (P3A-Type) as a New Apoptotic-Cell Membrane Receptor.The early transcriptional response of human granulocytes to infection with Candida albicans is not essential for killing but reflects cellular communications.
P2860
Q33233557-E49EF82F-2F54-45FA-BB45-6B974E6A1A8EQ33862289-8C3731CB-E7D1-4046-B22E-EC9F763AFC90Q33927464-22FD572C-734F-4D2D-B11E-EF2373622B9AQ33967488-3B326A24-E887-4A87-8EA3-46053260B96FQ35666413-C36AC205-9E2F-43EF-96B8-2A4B62670193Q35955162-DA756E8C-4963-4F32-8F50-6E17C2DF8DF4Q36538861-7100E0E9-BBCF-4B80-8CBD-41616200CB14Q37132306-82CDD2D0-AAE1-430C-B7F1-BA3A334EDD2CQ37246851-846CD4C5-CADE-4CB5-B910-FC9D26D512F3Q37590545-7EA06045-865C-4BE4-B659-11869191F81DQ37954721-BE973825-5CED-4380-9743-D660AB8BA6F7Q38045004-5C8957F1-0AD1-4216-A919-7982FC54A9F7Q38126538-6F77F544-E377-4233-BBFD-2C0426FD66CEQ38635409-847522F0-CE61-4A81-8CB1-2323A131FCEFQ41962388-E7479DBF-E371-4E04-BA2E-321ED81EDF87Q42068798-A6A01D99-8DF7-4C7B-B57C-E0D87E23B73A
P2860
Different anti-Candida activities of two human lactoferrin-derived peptides, Lfpep and kaliocin-1.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Different anti-Candida activit ...... eptides, Lfpep and kaliocin-1.
@en
Different anti-Candida activit ...... eptides, Lfpep and kaliocin-1.
@nl
type
label
Different anti-Candida activit ...... eptides, Lfpep and kaliocin-1.
@en
Different anti-Candida activit ...... eptides, Lfpep and kaliocin-1.
@nl
prefLabel
Different anti-Candida activit ...... eptides, Lfpep and kaliocin-1.
@en
Different anti-Candida activit ...... eptides, Lfpep and kaliocin-1.
@nl
P2860
P1476
Different anti-Candida activit ...... peptides, Lfpep and kaliocin-1
@en
P2093
José F Fierro
Mónica Viejo-Díaz
P2860
P304
P356
10.1128/AAC.49.7.2583-2588.2005
P407
P577
2005-07-01T00:00:00Z